Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023 at 16:00 PM EST
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a co-founder of Structure Therapeutics.
